Pharmafile Logo

What we do and who we do it for | Pegasus

We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital and social. One that creates all of its content in-house. One that’s transparent and measurable.

Why? Because health conversations are happening everywhere, all of the time. Every day we all make decisions that impact on the quality of our own, and often other people’s, health. From the food we eat, the products we put on our skin, the medicines we take or the routines we create to prevent or manage illness. We might be a healthcare professional, a policy maker, a businessman, a patient, a parent or a combination of all these. We could be in a doctor’s surgery, at home, in the gym, or on the go. Whoever we are, wherever we are, and whatever we are doing, the ability to make healthy decisions, consciously or not, will benefit us as individuals and beyond.

This is a new approach to health communications.

This is Pegasus.

Find out more at info@thisispegasus.co.uk or by calling +44 (0) 1273 712 000.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Free Thinking: From promise to practice: immuno-oncology in action

This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...

Exploring the Opportunity For Halal In Healthcare

Published in Medical Marketing & Media November 2015

Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets

Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets

12 Challenges Big Pharma Faces in China

Published in eyeforpharma 16 November by Rachel Howard

Using mobile “diary” research to capture patient-generated insights in COPD

Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients

Biosimilars in 2018: EU doctors’ perceptions of RA drug market

Published in pharmaphorum October 2015 by Laurent Chanroux

Webinar: Understanding the Patient Journey in China 2015

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

Understanding Patient Willingness to Pay

Published in eyeforpharma 12 October by Rachel Howard

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.